GoodRx Holdings, Inc. (GDRX) earnings
Quarterly results of GoodRx Holdings, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
GoodRx Holdings, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) GoodRx Holdings, Inc. reported revenue of $200.4M (-1.3% on the same quarter a year earlier) and net income of $8.5M (-33.5% on the same quarter a year earlier).
Diluted earnings per share were $0.02 (-50% on the same quarter a year earlier).
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $200.4M | -1.3% | $8.5M | $0.02 |
| Q1 FY2026 | $194M | -4.4% | $1.2M | $0.00 |
| Q4 FY2025 | $194.8M | -1.9% | $5.4M | - |
| Q3 FY2025 | $196M | +0.4% | $1.1M | $0.00 |
| Q2 FY2025 | $203.1M | - | $12.8M | $0.04 |
| Q1 FY2025 | $203M | - | $11.1M | $0.03 |
| Q4 FY2024 | $198.6M | - | $6.7M | - |
| Q3 FY2024 | $195.3M | - | $4M | $0.01 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
When is GoodRx Holdings, Inc.'s next earnings date?
GoodRx Holdings, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
What were GoodRx Holdings, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, GoodRx Holdings, Inc. reported revenue of $200.4M and net income of $8.5M (-33.5% on the same quarter a year earlier). The figures come from its filing with the SEC.
Is GoodRx Holdings, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $200.4M, down 1.3% from $203.1M in the same quarter a year earlier.
Get an email when GDRX reports
Follow GDRX and we email you its next results the day they are filed, with the numbers explained.